Conferences on January 10, 2013

The New Paradigms to Fund and Advance Drug Development was held in January 10-12, 2012. Attended by all levels of Biotech CEOs, R&D leaders and the Investment community, the conference delivered information on alternative sources of funding, non-traditional partnering strategies and innovative approaches to drug approval for the successful commercialization of new therapies. 10% Discount to EIN Readers with the code EINNP

2013 ICSSB is a forum of communication for academics, researchers, practitioners, and policymakers in the areas of social science and business. Through its broadly defined scope, we welcome interdisciplinary perspectives such as politics, psychology, government and management.2013 ICSSB provides an outlet for high-quality refereed empirical research on all aspects of social science and business. Purely theoretical research with the potential for empirical applications and in depth literature reviews will also be considered. If you have any query, please don’t hesitate to contact us by icssb@icssb.org.

2013 International Congress on, Chemical, Biological and Environmental Sciences 2013 ICCBES @ Taipei, Taiwan 8-10 January, 2013 www.iccbes.org GENERAL INFORMATION ICCBES'2013International Conference on, Chemical, Biological and Environmental Sciences aimed at presenting current research being carried out in that area. The idea of the conference is for the scientists, scholars, engineers and students from the Universities all around the world and the industry to present ongoing research activities, and hence to foster research relations between the universities and the industry. This conference provides opportunities for the delegates to exchange new ideas and application experiences face to face, to establish business or research relations and to find ...

2013 ICNSE will be held during January 08-10, 2013, in Taipei, Taiwan. 2013 ICNSE aims to bring together researchers, scientists, engineers, and scholar students to exchange and share their experiences, new ideas, and research results about all aspects of Natural Science and Engineering, and discuss the practical challenges encountered and the solutions adopted. All accepted papers will be published in the ICNSE 2013 proceedings, and will be included in the Engineering & Technology Digital Library, and indexed by EBSCO, WorldCat, Google Scholar, CNKI, Ulrich's Periodicals Directory and sent to be reviewed by ISI Proceedings. Prospective authors are invited to abstracts / submit full and original research papers, and English is the official language of the conference. The conference ...

This webinar will provide a basic understanding of regulations and statutes that people involved in the clinical research contract negotiation process must be aware of. You will learn how to negotiate for and create federally complaint agreements and thus avoid the risk associated with violations. Why Should You Attend: Payment for work done in the execution of a clinical trial would seem to be a straightforward proposition, but in the U.S. a multitude of regulations and statutes and their associated risk can turn contract and budget negotiation into a minefield. Such regulations include the Stark Law, the Anti-kickback Statute, the False Claims Act and Medicare Secondary Payer Rule. All parties involved in the clinical research contract negotiation process must be well versed in these ...

This webinar will examine the issues in FDA quality audit sampling and provide answers you need to plan your audit. You will learn the difference between counting nonconformities and counting non-conformances and the proper technique for a quality audit.

This webinar on gluten-free labeling will detail the efforts made by the USFDA pursuant to the obligations mandated by the Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA). It will show how foods manufacturers and labelers may use the term “gluten-free” in product labeling and what this distinction means. This webinar will highlight the Agency’s action with respect to developing gluten-free regulations and the current status of these requirements.

Conference Aim The main aim of Annual Symposium on Management, Operations Research and Economics (ASMOR 2013) is to provide an international platform for academics, researchers and scholars from all over the world to come together to exchange ideas on Management, Operations Research and Economics. The Conference will address the needs of all participants. Submitted papers will be double blind peer reviewed. Accepted papers will be published in ISSN-ed CD Conference Proceedings.

Please join us in celebrating the 10th anniversary of CHI's High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Tenth Annual High-Content Analysis 2013 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, and novel biological models for screening. We will also cover case studies and applications in compound screening, cytotoxicity evaluation, stem cell research, functional analysis, and more.

THE ALL SECTOR GLOBAL b2b marketplace Few other platforms in the world can boast of a single premise where there can be buyer seller meets, international conferences, business networking, technology assessments, strategic partnerships, vendor development in not one but multi-industry sectors. VGGTS has been strategically planned to incorporate all of the key focus sectors within the exhibition area to give to all exhibitors the advantage of inter-sectoral business opportunities. The Government of Gujarat has been super-successfully organizing the biennial Vibrant Gujarat Global Investors’ Summit – since year 2003. Over the years, this summit has emerged as one of the most significant events, not only in India, but also on an international scale, often being compared to ...